Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy

    Antonella Vaccarino, Irene Dogliotti, Fabio Marletto, Andrea Demarchi, Mario Bazzan
    e2016050
    2016-10-20
    https://doi.org/10.4084/mjhid.2016.050
    2994
    PDF: 839
    HTML: 1342
    Blood Count trend before and during lenalidomide treatment: 254
    Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 250
  • Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin

    Caterina Giovanna Valentini, Valentina Bozzoli, Anna Rita Larici, Luigi Maria Larocca, Giovanni Delogu, Giuseppe Leone, Livio Pagano
    e2012040
    2012-06-18
    https://doi.org/10.4084/mjhid.2012.040
    2178
    PDF: 790
    HTML: 19682
  • As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report

    Aylin Canbolat Ayhan, Korhan ozkan, Cetin Timur, Birol Aktaş, Ayse Bahar Ceyran
    e2013043
    2013-06-06
    https://doi.org/10.4084/mjhid.2013.043
    1861
    PDF: 699
    HTML: 1569
    Figure 1: MRI demonstrating Aspergillus synovitis: 239
    Figure 2:MRI demonstrating Aspergillus synovitis: 271
  • Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET

    Alessandro Gozzetti, Vania Rossi, Alfonso Cerase, Giulia Papini, Marzia Defina, Monica Bocchia
    e2012041
    2012-06-19
    https://doi.org/10.4084/mjhid.2012.041
    1241
    PDF: 825
    HTML: 784
  • Late-onset hepatic veno-occlusive disease after allografting: report of two cases with atypical clinical features successfully treated with defibrotide.

    Alessia Castellino, Stefano Guidi, Chiara Dellacasa, Antonella Gozzini, Irene Donnini, Chiara Nozzoli, Sara Manetta, Semra Aydin, Luisa Giaccone, Moreno Festuccia, Lucia Brunello, Enrico Maffini, Benedetto Bruno, Ezio David, Alessandro Busca
    e2018001
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.001
    4527
    PDF: 1221
    HTML: 1056
  • POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.

    Sinem Başak Tan Öksüz, Güldane Cengiz Seval, Klara Dalva, Selami Koçak Toprak
    e2026028
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.028
    1298
    PDF: 686
    Suppl. Files: 159
    HTML: 555
  • TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo
    e2025039
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.039
    2749
    PDF: 1850
    HTML: 744
  • GENETIC PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IN CHILDHOOD AND ADOLESCENCE

    Francesco Fabozzi, Angela Mastronuzzi
    e2023032
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.032
    2265
    PDF: 603
    HTML: 644
  • LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.

    Andrea Riccardo Filippi
    e2016041
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.041
    3990
    PDF: 1207
    HTML: 2535
    Figure 1: 253
  • PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations

    Michele Bibas
    e2024007
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.007
    3880
    PDF: 2680
    HTML: 1721
  • THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

    Xenofon Papanikolaou, Bart Barlogie, Saad Usmani
    e2011047
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.047
    2679
    PDF: 891
    HTML: 1768
  • LIGHT CHAIN AMYLOIDOSIS

    Paolo Milani, Giampaolo Merlini, Giovanni Palladini
    e2018022
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.022
    6610
    PDF: 2525
    HTML: 1594
  • MAGNUSIOMYCES CAPITATUS BREAKTHROUGH INFECTION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RECEIVING ECHINOCANDIN PROPHYLAXIS: CLINICAL FEATURES, MANAGEMENT, AND REVIEW OF THE LITERATURE

    Claudia Gomez-Hernandez, Carmen Corrales, Pedro José Mirete, Soraya Ramos, Mireia Micó-Cerdà, Clara Martinez-Lopez, Juan Carlos Hernandez-Boluda, Carlos Solano, Rafael de la Camara, Jose Luis Piñana
    e2026072
    2026-09-01
    https://doi.org/10.4084/MJHID.2026.072
    216
    PDF: 255
    Suppl. Files: 49
    Html: 122
    Html Suppl. Files: 109
  • An unusual cause of anemia and encephalopathy

    Sanjeev Kumar Sharma, Dharma Choudhary, Anil Handoo, Gaurav Dhamija, Gaurav Kharya, Vipin Khandelwal, Mayank Dhamija, Sweta Kothari
    e2015036
    2015-04-24
    https://doi.org/10.4084/mjhid.2015.036
    4276
    PDF: 952
    HTML: 1563
  • ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children

    Ilaria Lazzareschi, Elena Rossi, Antonietta Curatola, Giovanna Capozio, Luca Benacquista, Ludovica Iezzi, Donato Rigante
    e2022008
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.008
    2753
    PDF: 1307
    HTML: 1126
  • MANAGING INVASIVE FUNGAL INFECTIONS DURING ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION: A 2025 UPDATE

    Martina Quattrone, Alessia Di Pilla, Sara Brunetti, Antonio Giordano, Luana Fianchi, Livio Pagano, Marianna Criscuolo
    e2025064
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.064
    2760
    PDF: 1090
    HTML: 338
  • INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE

    Duni Sawadogo, Aissata Tolo, Hermance Kassi, Mahawa Sangare, Andre Inwoley
    e2013023
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.023
    2168
    PDF: 870
    HTML: 740
    Table1: patient's characteristics: 272
    Table 2: profile of each patient: 250
  • IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS

    Alana Kennedy-Nasser, Catherine Bollard, Helen Heslop
    e2009010
    2009-11-13
    https://doi.org/10.4084/mjhid.2009.010
    1329
    PDF: 664
    HTML: 6944
  • DIAMOND BLACKFAN ANEMIA: A TERTIARY CARE CENTRE EXPERIENCE

    avinash kumar singh, tulika seth, nita radhakrishnan, pravas mishra, manoranjan mahapatra, haraprasad pati
    e2013039
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.039
    2828
    PDF: 943
    HTML: 3624
    Diamond Blackfan Anemia: A Tertiary care centre experience: 385
  • Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax

    Claudio Fozza
    e2024011
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.011
    1890
    PDF: 1476
    HTML: 203
  • POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

    Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles
    e2010016
    2010-06-19
    https://doi.org/10.4084/mjhid.2010.016
    1269
    PDF: 854
    HTML: 606
  • THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION

    Sumit Dahal, Smrity Upadhyay, Rashmi Banjade, Prajwal Dhakal, Navin Khanal, Vijaya Raj Bhatt
    e2017019
    2017-03-01
    https://doi.org/10.4084/mjhid.2017.019
    4470
    PDF: 2140
    HTML: 1981
  • CUTANEOUS MANIFESTATIONS OF PRIMARY IMMUNODEFICIENCY DISEASES IN TUNISIAN CHILDREN

    Naouel GUIRAT, Monia Ben Khaled, Monia Ouederni, Imen Ben-Mustapha, Ridha Kouki, Habib Besbes, Mohamed Ridha Barbouche, Fethi Mellouli, mohamed bejaoui
    e2018065
    2018-10-30
    https://doi.org/10.4084/mjhid.2018.065
    2049
    PDF: 1222
    HTML: 453
  • IRON METABOLISM IN THALASSEMIA AND SICKLE CELL DISEASE

    Raffaella Mariani, Paola Trombini, Matteo Pozzi, Alberto Piperno
    e2009006
    2009-10-27
    1794
    PDF: 730
    HTML: 43979
  • HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19

    Stefano Botti, Nicola Serra, Fausto Castagnetti, Sabina Chiaretti, Nicola Mordini, Gianpaolo Gargiulo, Laura Orlando
    e2021011
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.011
    1886
    PDF: 697
    HTML: 315
  • LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML

    Xavier Thomas, Marica Laurino, sandrine loron, marie-virginie larcher, gaëlle fossard, mohamed elhamri, alexandre deloire, marie balsat, fiorenza barraco, hélène labussière, sophie ducastelle, myriam renault, eric wattel, maël heiblig, gilles salles
    e2020020
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.020
    2065
    PDF: 1273
    HTML: 358
  • IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis

    Derya Alabaz, Fadime Eroğlu, Hüseyin Elçi, Ümmühan Çay
    e2022053
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.053
    1250
    PDF: 801
    HTML: 295
  • MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.

    Maria Ilaria Del Principe
    e2016052
    2016-10-20
    https://doi.org/10.4084/mjhid.2016.052
    5284
    PDF: 1400
    HTML: 1950
    Untitled: 248
    Untitled: 241
  • How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency

    Marco Sanna, Giovanni Caocci, Giorgio La Nasa
    e2017047
    2017-08-14
    https://doi.org/10.4084/mjhid.2017.047
    1965
    PDF: 1016
    HTML: 1040
    Referring article: 813
  • Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma

    Muzaffer Keklik, Serdar Sivgin, Cigdem Pala, Celalettin Eroglu, Gulsah Akyol, Leylagul Kaynar, Mustafa Yavuz Koker, Demet Camlica, Ali Unal, Mustafa Cetin, Bulent Eser
    e2012063
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.063
    1619
    PDF: 807
    HTML: 4609
    Figure 1: Chest radiograph: 288
    Figure 2: Flow cytometer analysis of pleural fluid: 250
  • INFLUENZA AND PNEUMOCOCCAL VACCINATION IN HEMATOLOGICAL MALIGNANCIES: A SYSTEMATIC REVIEW OF EFFICACY, EFFECTIVENESS AND SAFETY

    Giuseppe La Torre
    e2016044
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.044
    4900
    PDF: 1608
    HTML: 3488
  • DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA

    Sabina Chiaretti, Gina Zini, Renato Bassan
    e2014073
    2014-10-24
    https://doi.org/10.4084/mjhid.2014.073
    9641
    PDF: 6367
    HTML: 88347
    Fig.1b: 315
    Fig.1c: 317
    Fig.2a: 313
    Fig.2b: 278
    Fig.4: 342
    Fig.2c: 299
    Fig.3: 298
    Tab.1: 359
    Tab.2: 328
    Tab.3: 322
    Tab.4: 368
    Fig1a: 311
  • PROGNOSTIC SIGNIFICANCE OF NRAS GENE MUTATIONS IN CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA

    Rabab Aly, Mohamed R. El-sharnoby, Adel A. Hagag
    e2011055
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.055
    2015
    PDF: 861
    HTML: 1594
  • Very late onset Post-Transplantation Lymphoproliferative Disorder (PTLD) after haematopoietic stem cell transplant (HCT) – A Clinical Case

    Sharon Lionel, Liron Barnea Slonim, Guy Hannah, Victoria Potter, Daniele Avenoso
    e2024048
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.048
    1210
    PDF: 1073
    HTML: 177
  • Molecular Expression of bone marrow angiogenic factors, cell-cell adhesion molecules and matrix-metallo-proteinase plasma cellular disorders: a molecular panel to investigate disease progression

    Maria Cristina Rapanotti
    e2018059
    2018-10-30
    https://doi.org/10.4084/mjhid.2018.059
    1475
    PDF: 882
    HTML: 222
  • Bortezomib a safety treatment for patients with Multiple Myeloma and Cystic Fibrosis

    Fabiana Gentilini, Anna Levi, Vincenzo Federico, Eleonora Russo, Robin Foà, Maria Teresa Petrucci
    e2012035
    2012-05-07
    https://doi.org/10.4084/mjhid.2012.035
    1789
    PDF: 837
    HTML: 680
  • A novel germline JAK2 splice-site variant causing exon 10 skipping in a patient with clinically diagnosed essential thrombocythemia and early-onset tophaceous gout: a case report

    Xun Zhu, Yaomei Long, Liye Zhong, Xiuli Wu, Ling Xu, Jie Wu
    e2026083
    2026-10-31
    https://doi.org/10.4084/MJHID.2026.083
    94
    PDF: 39
    Suppl. Files: 23
    Html: 37
    Html Suppl. Files: 12
  • CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY

    Daichi Inoue, Hayato Maruoka, Takayuki Takahashi
    e2010020
    2010-08-05
    https://doi.org/10.4084/mjhid.2010.020
    1420
    PDF: 815
    HTML: 1255
  • Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients

    Gianmarco Bagnato, Vittorio Stefoni, Alessandro Broccoli, Lisa Argnani, Cinzia Pellegrini, Beatrice Casadei, Francesca Bonifazi, Pier Luigi Zinzani
    e2024004
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.004
    1629
    PDF: 1516
    HTML: 232
  • MOLECULAR HETEROGENEITY IN ACUTE PROMYELOCYTIC LEUKEMIA - A SINGLE CENTRE EXPERIENCE FROM INDIA

    Nikhil Rabade, Goutham Raval, Shruti Chaudhary, PG Subramanian, Rohan Kodgule, Swapnali Joshi, Prashant Tembhare, Hasmukh Jain, Manju Sengar, Syed Hasan K, Pratibha Amare Kadam, Dhanalaxmi Shetty, Gaurav Narula, Shripad Banavali, Sumeet Gujral, Nikhil Patkar
    e2018002
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.002
    3837
    PDF: 1315
    HTML: 1138
  • DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE

    Paola Zanotti, Claudia Chirico, Maurizio Gulletta, Laura Ardighieri, Salvatore Casari, Eugenia Quiros Roldan, Ilaria Izzo, Gabriele Pinsi, Giovanni Lorenzin, Fabio Facchetti, Francesco Castelli, Emanuele Focà
    e2018040
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.040
    4062
    PDF: 1410
    HTML: 989
    Figure 2: 535
    Figure 1: 3218
  • MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT

    Alfredo Marzano
    e2009025
    https://doi.org/10.4084/mjhid.2009.025
    953
    PDF: 536
    HTML: 1333
  • Successful treatment of gastric relapse in multiple myeloma with bortezomib after autologous hematopoietic stem cell transplantation (autoHSCT)

    Serdar Sivgin
    e2013006
    2013-01-02
    https://doi.org/10.4084/mjhid.2013.006
    1271
    PDF: 710
    HTML: 3374
  • ?-THALASSEMIA DISTRIBUTION IN THE OLD WORLD: A HISTORICAL STANDPOINT OF AN ANCIENT DISEASE

    Vincenzo De Sanctis
    e2017018
    2017-02-20
    https://doi.org/10.4084/mjhid.2017.018
    11820
    PDF: 4564
    HTML: 5067
  • Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

    Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda
    e2025026
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.026
    2177
    PDF: 1818
    HTML: 496
  • COMPARISON OF THREE DISTINCT PROPHYLACTIC AGENTS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS UNDERGOING HAPLO-IDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AND POST-TRANSPLANT CYCLOPHOSPHAMIDE

    Jean Elcheikh
    e2015048
    2015-08-21
    https://doi.org/10.4084/mjhid.2015.048
    2061
    PDF: 1121
    HTML: 1411
  • EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?

    Pellegrino Musto, Dr. Nicola Sgherza
    e2024073
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.073
    1721
    PDF: 924
    HTML: 374
  • FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells

    Eugenio Galli, Filippo Frioni, Tanja Malara, Enrico Attardi, Silvia Bellesi, Stefan Hohaus, Simona Sica, Federica Sorà, Patrizia Chiusolo
    e2024029
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.029
    1159
    PDF: 1325
    HTML: 145
  • MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman

    Davide Matino, Paul Tieu, Dr., Antony Chan
    e2020001
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.001
    3655
    PDF: 1733
    HTML: 758
  • A PROSPECTIVE STUDY OF BRUCELLOSIS IN CHILDREN: RELATIVE FREQUENCY OF PANCYTOPENIA

    Mohamed El Koumi, Mona Afify, Salha Al-Zahrani
    e2013011
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.011
    2383
    PDF: 932
    HTML: 4053
151 - 200 of 453 items << < 1 2 3 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.